Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kesuting syrup for mild COVID-19
ChiCTR2200059724Phase 4Completed
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kesuting in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoints: Cough efficacy and Cough disappearance time. Started May 2022; status: completed.
02
Drugs
kesuting
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200059724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059724.